Joan S. Brugge is a venture partner at Catalio Capital Management and a professor of cell biology and director of the Ludwig Cancer Center at Harvard Medical School. She researches cancer biology and co-founded ARIAD Pharmaceuticals, which was acquired by Takeda.
Joan S. Brugge is a venture partner at Catalio Capital Management and a professor of cell biology and director of the Ludwig Cancer Center at Harvard Medical School. She researches cancer biology and co-founded ARIAD Pharmaceuticals, which was acquired by Takeda.
Career
Joan S. Brugge holds a BA from Northwestern University and a PhD from Baylor College of Medicine.
Venture Partner at Catalio Capital Management until PresentHMProfessor of Cell Biology; Director, Ludwig Cancer Center at Harvard Medical School until Present